REFERENCES

1. Green DR, Victor B. The pantheon of the fallen: why are there so many forms of cell death? Trends Cell Biol 2012;22:555-6.

2. Pandian N, Kanneganti TD. PANoptosis: a unique innate immune inflammatory cell death modality. J Immunol 2022;209:1625-33.

3. Lee S, Karki R, Wang Y, Nguyen LN, Kalathur RC, Kanneganti TD. AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence. Nature 2021;597:415-9.

4. Xu X, Lan X, Fu S, et al. Dickkopf-1 exerts protective effects by inhibiting PANoptosis and retinal neovascularization in diabetic retinopathy. Biochem Biophys Res Commun 2022;617:69-76.

5. Lu M, Marsters S, Ye X, Luis E, Gonzalez L, Ashkenazi A. E-cadherin couples death receptors to the cytoskeleton to regulate apoptosis. Mol Cell 2014;54:987-98.

6. Olcum ML, Fan RS, Gonzales MM, et al. PANoptosis is a prominent feature of desmoplakin cardiomyopathy. J Cardiovasc Aging 2023;3:3.

7. Kowalczyk AP, Green KJ. Structure, function, and regulation of desmosomes. Prog Mol Biol Transl Sci 2013;116:95-118.

8. Lin T, Conti S, Cipolletta L, et al. Right ventricular outflow tract arrhythmias: benign or early stage arrhythmogenic right ventricular cardiomyopathy/dysplasia? J Atr Fibrillation 2014;7:1161.

9. Chelko SP, Asimaki A, Andersen P, et al. Central role for GSK3β in the pathogenesis of arrhythmogenic cardiomyopathy. JCI Insight 2016;1:85923.

The Journal of Cardiovascular Aging
ISSN 2768-5993 (Online)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/